Business Information
The group's principal activities are to develop, manufacture and market medication delivery systems, critical care devices and specialty injectable pharmaceuticals. The medication delivery systems consists of electronic drug delivery pumps, administration sets and accessories and infusion therapy products to deliver intravenous fluids and medications to patients. The critical care devices are used to monitor cardiac functions in critically ill patients. The specialty injectable pharmaceuticals include generic injectable pharmaceutical products and proprietary injectable pharmaceuticals used in a specific patient population or therapeutic area. It also provides contract manufacturing services to pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals. The products offered by the group are used by hospitals, alternate site clinics, home healthcare providers and long-term care facilities.
|
|
Name |
Title
|
Email
|
| Christopher Begley | Chmn., CEO - Hospira, Inc | N/A | | Edward Ogunro | Sr. VP - Research & Development, R&D, Medical Affairs, Chief Scientific Officer | N/A | | Terrence Kearney | COO | N/A | | Thomas Werner | CFO, Sr. VP - Finance | N/A | | Brian Smith | Sr. VP, General Counsel, Sec. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 2,688,505 | 237,679 | | 2005 | 2,626,696 | 235,638 | | 2004 | 2,645,036 | 301,552
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
